18-46560082-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001384474.1(LOXHD1):c.3061+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000427 in 703,306 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000064 ( 0 hom., cov: 26)
Exomes 𝑓: 0.000037 ( 0 hom. )
Consequence
LOXHD1
NM_001384474.1 splice_donor, intron
NM_001384474.1 splice_donor, intron
Scores
1
4
2
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 7.17
Genes affected
LOXHD1 (HGNC:26521): (lipoxygenase homology PLAT domains 1) This gene encodes a highly conserved protein consisting entirely of PLAT (polycystin/lipoxygenase/alpha-toxin) domains, thought to be involved in targeting proteins to the plasma membrane. Studies in mice show that this gene is expressed in the mechanosensory hair cells in the inner ear, and mutations in this gene lead to auditory defects, indicating that this gene is essential for normal hair cell function. Screening of human families segregating deafness identified a mutation in this gene which causes DFNB77, a progressive form of autosomal-recessive nonsyndromic hearing loss (ARNSHL). Alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Mar 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, No cryptic splice site detected. Exon removal results in frameshift change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-46560082-C-T is Pathogenic according to our data. Variant chr18-46560082-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 523622.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr18-46560082-C-T is described in Lovd as [Likely_pathogenic]. Variant chr18-46560082-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LOXHD1 | NM_001384474.1 | c.3061+1G>A | splice_donor_variant, intron_variant | ENST00000642948.1 | NP_001371403.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LOXHD1 | ENST00000642948.1 | c.3061+1G>A | splice_donor_variant, intron_variant | NM_001384474.1 | ENSP00000496347.1 | |||||
LOXHD1 | ENST00000536736.5 | c.3061+1G>A | splice_donor_variant, intron_variant | 5 | ENSP00000444586.1 | |||||
LOXHD1 | ENST00000441551.6 | c.2599-2593G>A | intron_variant | 5 | ENSP00000387621.2 | |||||
LOXHD1 | ENST00000335730.6 | n.2374+1G>A | splice_donor_variant, intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000637 AC: 9AN: 141300Hom.: 0 Cov.: 26
GnomAD3 genomes
AF:
AC:
9
AN:
141300
Hom.:
Cov.:
26
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000374 AC: 21AN: 561886Hom.: 0 Cov.: 28 AF XY: 0.0000308 AC XY: 9AN XY: 291910
GnomAD4 exome
AF:
AC:
21
AN:
561886
Hom.:
Cov.:
28
AF XY:
AC XY:
9
AN XY:
291910
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000636 AC: 9AN: 141420Hom.: 0 Cov.: 26 AF XY: 0.0000729 AC XY: 5AN XY: 68574
GnomAD4 genome
AF:
AC:
9
AN:
141420
Hom.:
Cov.:
26
AF XY:
AC XY:
5
AN XY:
68574
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Autosomal recessive nonsyndromic hearing loss 77 Pathogenic:4
Likely pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | MGZ Medical Genetics Center | Aug 23, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 04, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Center of Genomic medicine, Geneva, University Hospital of Geneva | Nov 20, 2017 | This homozygous variant in LOXHD1 was identified in a female patient with congenital bilateral moderate hearing loss. This variant is present in an heterozygous state in the mother. The father could not be tested. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 26, 2023 | This sequence change affects a donor splice site in intron 19 of the LOXHD1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in LOXHD1 are known to be pathogenic (PMID: 19732867, 21465660, 25792669). This variant is present in population databases (rs537227442, gnomAD 0.006%). Disruption of this splice site has been observed in individual(s) with deafness (PMID: 28000701, 29676012). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 523622). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Hearing impairment Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Department of Otolaryngology – Head & Neck Surgery, Cochlear Implant Center | Apr 12, 2021 | PVS1_Strong, PM2_Moderate - |
Hearing loss, autosomal recessive Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Center of Genomic medicine, Geneva, University Hospital of Geneva | Nov 20, 2017 | This homozygous variant in a splicing donor site in the LOXHD1 gene was identified in a young female patient with moderate bilateral deafness and developmental delay - |
LOXHD1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 19, 2024 | The LOXHD1 c.3061+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. This variant has been reported in the compound heterozygous or homozygous state in individuals with hearing loss (Table S4, Zazo Seco et al. 2017. PubMed ID: 28000701; Van Heurck et al 2021. PubMed ID: 34440452; Wesdorp et al. 2018. PubMed ID: 29676012). This variant is reported in 0.0059% of alleles in individuals of African descent in gnomAD. Variants that disrupt the consensus splice donor site in LOXHD1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DG_spliceai
Position offset: -3
DS_DL_spliceai
Position offset: 1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at